Investor profile
Noshaq has backed 24 European tech companies across 26 funding rounds between 2021 and 2026, joining rounds totalling €182M. Most active in Healthtech and Agritech. Data as of 6 Aug 2026.
Also recorded as: Noshaq Group
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| Standing Ovation | France | 1 | €30M |
| Sunrise | Belgium | 1 | €25M |
| CryoTherapeutics | Belgium | 2 | €22M |
| PDC*line Pharma | Belgium | 1 | €18M |
| Axithra | Belgium |
| Company | Stage | Amount | Date |
|---|---|---|---|
| Standing Ovation | Series B | €30M | 2026-03 |
| Sunrise | Other | €25M | 2025-09 |
| PDC*line Pharma | Series B | €18M | 2021-12 |
| CryoTherapeutics |
| 1 |
| €10M |
| Ampacimon | Belgium | 1 | €10M |
| Lisaqua | France | 1 | €9.0M |
| Le Fourgon | France | 1 | €8.2M |
| Signatur Biosciences | UK | 1 | €6.2M |
| LIFEPOWR | Belgium | 1 | €5.7M |
| DeuterOncology | Belgium | 1 | €5.7M |
| Trustup | Belgium | 1 | €5.0M |
| Eclo | Belgium | 1 | €4.7M |
| HEPHAISTOS-Pharma | France | 1 | €4.3M |
| Samabriva | France | 1 | €4.0M |
| Raw Stadia | Belgium | 2 | €2.5M |
| ARK Capture Solutions | Belgium | 1 | €2.2M |
| Myocene | Belgium | 1 | €2.0M |
| MyCellHub | Belgium | 1 | €2.0M |
| Novobiom | Belgium | 1 | €2.0M |
| Hedera-22 | Belgium | 1 | €2.0M |
| IONNYK | Belgium | 1 | €1.0M |
| Get Your Way | Belgium | 1 | €850k |
| Ivex | Belgium | 1 | €0 |
| Other |
| €12M |
| 2022-02 |
| Ampacimon | Series C | €10M | 2023-10 |
| Axithra | Seed | €10M | 2023-09 |
| CryoTherapeutics | Series B | €10M | 2024-04 |
| Lisaqua | Other | €9.0M | 2025-10 |
| Le Fourgon | Series A | €8.2M | 2025-01 |
| Signatur Biosciences | Other | €6.2M | 2025-05 |
